West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 223.77 USD -0.41% Market Closed
Market Cap: 16.1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+17%
Revenue
Forecast
+6%
Operating Income
Forecast
-14%
Net Income
Forecast
-9%

Wall Street
Price Targets

WST Price Targets Summary
West Pharmaceutical Services Inc

Wall Street analysts forecast WST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WST is 283.2 USD with a low forecast of 247.45 USD and a high forecast of 341.25 USD.

WST Lowest Forecast
Wall Street Target
247.45 USD
11% Upside
WST Average Forecast
Wall Street Target
283.2 USD
27% Upside
WST Highest Forecast
Wall Street Target
341.25 USD
53% Upside
Lowest
Price Target
247.45 USD
11% Upside
Average
Price Target
283.2 USD
27% Upside
Highest
Price Target
341.25 USD
53% Upside
West Pharmaceutical Services Inc Competitors:
Price Targets
VIMTALABS
Vimta Labs Ltd
37% Downside
G
688046
GemPharmatech Co Ltd
54% Upside
R
RVU
Ryvu Therapeutics SA
147% Upside
CHEMM
Chemometec A/S
17% Upside
VIMTALABS
Vimta Labs Ltd
37% Downside
G
688046
GemPharmatech Co Ltd
54% Upside
R
RVU
Ryvu Therapeutics SA
147% Upside
CHEMM
Chemometec A/S
17% Upside
CDXS
Codexis Inc
204% Upside
Q
QSI
Quantum-Si Inc
69% Upside
CTKB
Cytek Biosciences Inc
49% Upside
SHC
Sotera Health Co
25% Upside

Revenue
Forecast

Revenue Estimate
West Pharmaceutical Services Inc

For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's revenue is 8%. The projected CAGR for the next 3 years is 5%.

8%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
West Pharmaceutical Services Inc

For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's operating income is 13%. The projected CAGR for the next 3 years is 7%.

13%
Past Growth
7%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
West Pharmaceutical Services Inc

For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's net income is 17%. The projected CAGR for the next 3 years is 7%.

17%
Past Growth
7%
Estimated Growth
Estimates Accuracy
2%
Average Beat
What are analyst estimates?

See Also

Summary
WST intrinsic value, competitors valuation, and company profile.
DCF Valuation
WST stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WST stock valuation using valuation multiples.
Wall Street Estimates
WST price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WST stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WST's stock price target?
Price Target
283.2 USD

According to Wall Street analysts, the average 1-year price target for WST is 283.2 USD with a low forecast of 247.45 USD and a high forecast of 341.25 USD.

What is West Pharmaceutical Services Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's revenue is 8%. The projected CAGR for the next 3 years is 5%.

What is West Pharmaceutical Services Inc's Operating Income forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's operating income is 13%. The projected CAGR for the next 3 years is 7%.

What is West Pharmaceutical Services Inc's Net Income forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for West Pharmaceutical Services Inc's net income is 17%. The projected CAGR for the next 3 years is 7%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 260,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.